Requirement of Vascular Integrin α v β 3 for Angiogenesis
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Angiogenesis depends on the adhesive interactions of vascular cells. The adhesion receptor integrin α v β 3 was identified as a marker of angiogenic vascular tissue. Integrin α v β 3 was expressed on blood vessels in human wound granulation tissue but not in normal skin, and it showed a fourfold increase in expression during angiogenesis on the chick chorioallantoic membrane. In the latter assay, a monoclonal antibody to α v β 3 blocked angiogenesis induced by basic fibroblast growth factor, tumor necrosis factor-α, and human melanoma fragments but had no effect on preexisting vessels. These findings suggest that α v β 3 may be a useful therapeutic target for diseases characterized by neovascularization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the integrin a v b 3 is expressed on blood vessels in human wound granulation tissue but not in normal skin”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [61]
In the citing paper
“antibodies against this integrin block angiogenesis induced by FGF and TNF-a without affecting preexisting blood vessels”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [61]
Citations
Cites
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., & Gasparini, G. (1992) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/84.24.1875 · Cited by 1,775
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., & Folkman, J. (1990) · Nature · doi:10.1038/348555a0 · Cited by 1,299
Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α
Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V., & Nuseir, N. (1987) · Nature · doi:10.1038/329630a0 · Cited by 1,210
Cheresh, D. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6471 · Cited by 561
Self-citationCell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors.
Lawler, J., Weinstein, R., & Hynes, R. O. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.6.2351 · Cited by 474
Adams, J. C., & Watt, F. M. (1990) · Cell · doi:10.1016/0092-8674(90)90175-e · Cited by 448
Gladson, C. L., & Cheresh, D. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115516 · Cited by 417
Self-citationLeavesley, D. I., Schwartz, M. A., Rosenfeld, M., & Cheresh, D. A. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.1.163 · Cited by 391
Self-citationInvolvement of integrin alpha V gene expression in human melanoma tumorigenicity.
Felding-Habermann, B., Mueller, B. M., Romerdahl, C. A., & Cheresh, D. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115811 · Cited by 378
Self-citation
Research works printed but not linked: 1
- FOLKMAN, J, SEMINARS CANCER BIOL 3: 65 (1992).
Cited by
Items 301–400 of 1,011
The Role of Mechanical Stresses in Microvascular Remodeling
Skalak, T. C., & Price, R. J. (1996) · Microcirculation · doi:10.3109/10739689609148284 · Cited by 206
Tumor angiogenic vasculature targeting with PAMAM dendrimer–RGD conjugates
Shukla, R., Thomas, T. P., Peters, J., Kotlyar, A., Myc, A., & Baker, Jr. (2005) · Chemical Communications · doi:10.1039/b507350b · Cited by 205
Abdollahi, A., Griggs, D. W., Zieher, H., Roth, A., Lipson, K. E., Saffrich, R., Gröne, H.-J., Hallahan, D. E., Reisfeld, R. A., Debus, J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1223 · Cited by 205
Brain tumor-targeted drug delivery strategies
Wei, X., Chen, X., Ying, M., & Lu, W. (2014) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2014.03.001 · Cited by 205
Huang, Y., Shi, H., Zhou, H., Song, X., Yuan, S., & Luo, Y. (2006) · Blood · doi:10.1182/blood-2005-07-2961 · Cited by 205
Suzuki, Y., Tanihara, M., Suzuki, K., Saitou, A., Sufan, W., & Nishimura, Y. (2000) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(20000605)50:3<405::aid-jbm15>3.0.co;2-z · Cited by 205
Angiogenesis as a target in rheumatoid arthritis
Koch, A. E. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.suppl_2.ii60 · Cited by 204
Hak, S., Helgesen, E., Hektoen, H. H., Huuse, E. M., Jarzyna, P. A., Mulder, W. J. M., Haraldseth, O., & Davies, C. D. L. (2012) · ACS Nano · doi:10.1021/nn301630n · Cited by 204
Synthesis of Poly(β-amino ester)s with Thiol-Reactive Side Chains for DNA Delivery
Zugates, G. T., Anderson, D. G., Little, S. R., Lawhorn, I. E. B., & Langer, R. (2006) · Journal of the American Chemical Society · doi:10.1021/ja061570n · Cited by 204
Kireeva, M. L., Lam, S. C.-T., & Lau, L. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.3090 · Cited by 203
Characterization of Smooth Muscle Cell and Pericyte Differentiation in the Rat Retina In Vivo
Hughes, S., & Chan-Ling, T. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-1312 · Cited by 203
Gawaz, M., Neumann, F.-J., Dickfeld, T., Reininger, A., Adelsberger, H., Gebhardt, A., & Schömig, A. (1997) · Circulation · doi:10.1161/01.cir.96.6.1809 · Cited by 203
Bone-targeting macromolecular therapeutics
WANG, D., MILLER, S., KOPECKOVA, P., & KOPECEK, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.011 · Cited by 203
Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation
Chen, X., Park, R., Shahinian, A. H., Bading, J. R., & Conti, P. S. (2004) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2003.07.003 · Cited by 203
Kuek, V., Yang, Z., Chim, S. M., Zhu, S., Xu, H., Chow, S. T., Tickner, J., Rosen, V., Erber, W., Li, X., et al. (2016) · Scientific Reports · doi:10.1038/srep37482 · Cited by 202
Hydrogels with precisely controlled integrin activation dictate vascular patterning and permeability
Li, S., Nih, L. R., Bachman, H., Fei, P., Li, Y., Nam, E., Dimatteo, R., Carmichael, S. T., Barker, T. H., & Segura, T. (2017) · Nature Materials · doi:10.1038/nmat4954 · Cited by 202
Recent advances in molecular, multimodal and theranostic ultrasound imaging
Kiessling, F., Fokong, S., Bzyl, J., Lederle, W., Palmowski, M., & Lammers, T. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.013 · Cited by 201
The vascular endothelial growth factor family in adverse pregnancy outcomes
Andraweera, P. H., Dekker, G. A., & Roberts, C. T. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms011 · Cited by 201
In vivo therapy of malignant melanoma by means of antagonists of αv integrins
Mitjans, F., Meyer, T., Fittschen, C., Goodman, S. L., Jonczyk, A., Marshall, J. F., Reyes, G., & Piulats, J. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000901)87:5<716::aid-ijc14>3.0.co;2-r · Cited by 201
Gasparini, G., Longo, R., Fanelli, M., & Teicher, B. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.022 · Cited by 200
Kibria, G., Hatakeyama, H., Ohga, N., Hida, K., & Harashima, H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.012 · Cited by 200
Zhang, L., Su, H., Cai, J., Cheng, D., Ma, Y., Zhang, J., Zhou, C., Liu, S., Shi, H., Zhang, Y., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b06267 · Cited by 199
Huynh-Do, U. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2165 · Cited by 199
Anticoagulant and signaling functions of antithrombin
Rezaie, A. R., & Giri, H. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15052 · Cited by 199
Adventitial vasa vasorum in balloon-injured coronary arteries
Kwon, H. M., Sangiorgi, G., Ritman, E. L., Lerman, A., McKenna, C. J., Virmani, R., Edwards, W. D., Holmes, D. R., & Schwartz, R. S. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00482-3 · Cited by 199
Taga, T., Suzuki, A., Gonzalez‐Gomez, I., Gilles, F. H., Stins, M., Shimada, H., Barsky, L., Weinberg, K. I., & Laug, W. E. (2002) · International Journal of Cancer · doi:10.1002/ijc.10265 · Cited by 198
Kumar, C. C., Malkowski, M., Yin, Z., Tanghetti, E., Yaremko, B., Nechuta, T. L., Varner, J. A., Liu, M., Smith, E. M., Neustadt, B., et al. (2001) · PubMed · Cited by 198
Oba, M., Fukushima, S., Kanayama, N., Aoyagi, K., Nishiyama, N., Koyama, H., & Kataoka, K. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0700133 · Cited by 197
Specific Interaction of Angiostatin with Integrin αvβ3 in Endothelial Cells
Tarui, T., Miles, L. A., & Takada, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101815200 · Cited by 197
Nanomolar Small Molecule Inhibitors for αvβ6, αvβ5, and αvβ3 Integrins
Goodman, S. L., Hölzemann, G., Sulyok, G. A. G., & Kessler, H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0102598 · Cited by 196
Molecular imaging with targeted contrast ultrasound
Kaufmann, B. A., & Lindner, J. R. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.01.004 · Cited by 196
Angiogenesis: Models and Modulators
Cockerill, G. W., Gamble, J. R., & Vadas, M. A. (1995) · International Review of Cytology · doi:10.1016/s0074-7696(08)62106-3 · Cited by 195
Blockade of the αvβ3 Integrin Adversely Affects Implantation in the Mouse1
Illera, M. J., Cullinan, E., Gui, Y., Yuan, L., Beyler, S. A., & Lessey, B. A. (2000) · Biology of Reproduction · doi:10.1095/biolreprod62.5.1285 · Cited by 195
Regulation of VEGF/VPF expression in tumor cells: Consequences for tumor growth and metastasis
Claffey, K. P., & Robinson, G. S. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437469 · Cited by 194
New paradigms for the treatment of cancer: The role of anti-angiogenesis agents
(2000) · Advances in Cancer Research · doi:10.1016/s0065-230x(00)79001-4 · Cited by 193
Kopelman, R., Lee Koo, Y.-E., Philbert, M., Moffat, B. A., Ramachandra Reddy, G., McConville, P., Hall, D. E., Chenevert, T. L., Bhojani, M. S., Buck, S. M., et al. (2005) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2005.02.061 · Cited by 193
Von Willebrand factor and angiogenesis: basic and applied issues
Randi, A. M., & Laffan, M. A. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13551 · Cited by 193
Role of integrins in angiogenesis
Brooks, P. C. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00381-4 · Cited by 193
Self-citationYan, H., Wang, L., Wang, J., Weng, X., Lei, H., Wang, X., Jiang, L., Zhu, J., Lu, W., Wei, X., et al. (2012) · ACS Nano · doi:10.1021/nn203749v · Cited by 191
Wiesner, S., Legate, K. R., & Fässler, R. (2005) · CMLS Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4522-8 · Cited by 190
Integrins, angiogenesis and vascular cell survival
Strömblad, S., & Cheresh, D. A. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90176-3 · Cited by 190
Self-citationTarget-specific delivery of peptide-based probes for PET imaging
Chen, K., & Conti, P. S. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.09.004 · Cited by 190
Park, J. H., Kwon, S., Nam, J.-O., Park, R.-W., Chung, H., Seo, S. B., Kim, I.-S., Kwon, I. C., & Jeong, S. Y. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.020 · Cited by 190
Posey, J. A., Khazaeli, M. B., DelGrosso, A., Saleh, M. N., Lin, C. Y., Huse, W., & LoBuglio, A. F. (2001) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497801300189218 · Cited by 190
68Ga-labeled multimeric RGD peptides for microPET imaging of integrin αvβ3 expression
Li, Z.-B., Chen, K., & Chen, X. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0692-y · Cited by 190
The heparanase/syndecan‐1 axis in cancer: mechanisms and therapies
Ramani, V. C., Purushothaman, A., Stewart, M. D., Thompson, C. A., Vlodavsky, I., Au, J. L., & Sanderson, R. D. (2013) · The FEBS Journal · doi:10.1111/febs.12168 · Cited by 189
Regulators of angiogenesis and strategies for their therapeutic manipulation
Milkiewicz, M., Ispanovic, E., Doyle, J. L., & Haas, T. L. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.10.006 · Cited by 189
Schnittert, J., Bansal, R., Storm, G., & Prakash, J. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.020 · Cited by 188
Phosphatidylserine receptors: Enhancers of enveloped virus entry and infection
Moller-Tank, S., & Maury, W. (2014) · Virology · doi:10.1016/j.virol.2014.09.009 · Cited by 188
Bi-directional signal transduction by integrin receptors
Coppolino, M. G., & Dedhar, S. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00043-6 · Cited by 187
Matsumoto, T., Turesson, I., Book, M., Gerwins, P., & Claesson-Welsh, L. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200103096 · Cited by 187
Lewis, J. M., Cheresh, D. A., & Schwartz, M. A. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.5.1323 · Cited by 187
Self-citationMechanisms of tumour metastasis
Meyer, T., & Hart, I. R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10129-0 · Cited by 187
Cai, W., Wu, Y., Chen, K., Cao, Q., Tice, D. A., & Chen, X. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1480 · Cited by 187
Evaluation of tumor angiogenesis with US: Imaging, Doppler, and contrast agents
Ferrara, K. W., Merritt, C. R. B., Burns, P. N., Stuart Foster, F., Mattrey, R. F., & Wickline, S. A. (2000) · Academic Radiology · doi:10.1016/s1076-6332(00)80631-5 · Cited by 186
Patrolling the vascular borders: platelets in immunity to infection and cancer
Gaertner, F., & Massberg, S. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0202-z · Cited by 186
Barillari, G., Sgadari, C., Fiorelli, V., Samaniego, F., Colombini, S., Manzari, V., Modesti, A., Nair, B. C., Cafaro, A., Stürzl, M., et al. (1999) · PubMed · Cited by 185
β1 Integrin Is Essential for Teratoma Growth and Angiogenesis
Bloch, W., Forsberg, E., Lentini, S., Brakebusch, C., Martin, K., Krell, H. W., Weidle, U. H., Addicks, K., & Fässler, R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.1.265 · Cited by 185
Activation of tumor cell integrin α v β 3 controls angiogenesis and metastatic growth in the brain
Lorger, M., Krueger, J. S., O'Neal, M., Staflin, K., & Felding-Habermann, B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903035106 · Cited by 185
Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment
Cuenod, C. A., Fournier, L., Balvay, D., & Guinebretière, J.-M. (2006) · Abdominal Imaging · doi:10.1007/s00261-005-0386-5 · Cited by 185
Advances in the biology of bone metastasis: How the skeleton affects tumor behavior
Sterling, J. A., Edwards, J. R., Martin, T. J., & Mundy, G. R. (2011) · Bone · doi:10.1016/j.bone.2010.07.015 · Cited by 184
Cianfrocca, M. E., Kimmel, K. A., Gallo, J., Cardoso, T., Brown, M. M., Hudes, G., Lewis, N., Weiner, L., Lam, G. N., Brown, S. C., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603171 · Cited by 184
Filardo, E. J., Brooks, P. C., Deming, S. L., Damsky, C., & Cheresh, D. A. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.2.441 · Cited by 183
Self-citationAlbini, A. (1998) · Pathology & Oncology Research · doi:10.1007/bf02905254 · Cited by 183
Vascular involvement in rheumatic diseases: 'vascular rheumatology'
Szekanecz, Z., & Koch, A. E. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2515 · Cited by 183
Leong-Poi, H., Christiansen, J., Heppner, P., Lewis, C. W., Klibanov, A. L., Kaul, S., & Lindner, J. R. (2005) · Circulation · doi:10.1161/circulationaha.104.481515 · Cited by 182
Conde, J., Tian, F., Hernández, Y., Bao, C., Cui, D., Janssen, K., Ibarra, M. R., Baptista, P. V., Stoeger, T., & de la Fuente, J. M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.041 · Cited by 182
Pivotal role for decorin in angiogenesis
Järveläinen, H., Sainio, A., & Wight, T. N. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.023 · Cited by 182
Reinmuth, N., Liu, W., Ahmad, S. A., Fan, F., Stoeltzing, O., Parikh, A. A., Bucana, C. D., Gallick, G. E., Nickols, M. A., Westlin, W., et al. (2003) · PubMed · Cited by 181
Hypoxia as a target for combined modality treatments
Wouters, B. G., Weppler, S. A., Koritzinsky, M., Landuyt, W., Nuyts, S., Theys, J., Chiu, R. K., & Lambin, P. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00361-6 · Cited by 180
Bakhtiary, Z., Saei, A. A., Hajipour, M. J., Raoufi, M., Vermesh, O., & Mahmoudi, M. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.10.019 · Cited by 180
Rüegg, C., & Mariotti, A. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-2297-3 · Cited by 180
Nanotechnology in cancer therapy
Aslan, B., Ozpolat, B., Sood, A. K., & Lopez-Berestein, G. (2013) · Journal of Drug Targeting · doi:10.3109/1061186x.2013.837469 · Cited by 180
Cascone, I., Napione, L., Maniero, F., Serini, G., & Bussolino, F. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507082 · Cited by 179
Vimentin as an Integral Regulator of Cell Adhesion and Endothelial Sprouting
Dave, J. M., & Bayless, K. J. (2014) · Microcirculation · doi:10.1111/micc.12111 · Cited by 179
“These studies have important implications for vimentin’s role in regulating function of the a2b1, avb3, and a6b4 integrins, which have all been shown to mediate angiogenic sprouting in various assays [11,14,33].”
BackgroundStructure and function of RGD peptides involved in bone biology
Schaffner, P., & Dard, M. M. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180300008 · Cited by 179
van der Wel, P. C. A., Lewandowski, J. R., & Griffin, R. G. (2007) · Journal of the American Chemical Society · doi:10.1021/ja068633m · Cited by 179
Why Integrin as a Primary Target for Imaging and Therapy
Niu, G., & Chen, X. (2011) · Theranostics · doi:10.7150/thno/v01p0030 · Cited by 179
The Structural Biology of Protein Aggregation Diseases: Fundamental Questions and Some Answers
Eisenberg, D., Nelson, R., Sawaya, M. R., Balbirnie, M., Sambashivan, S., Ivanova, M. I., Madsen, A. Ø., & Riekel, C. (2006) · Accounts of Chemical Research · doi:10.1021/ar0500618 · Cited by 179
Angiogenesis and vasculogenesis in rheumatoid arthritis
Szekanecz, Z., Besenyei, T., Szentpétery, Á., & Koch, A. E. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328337c95a · Cited by 179
Nonclassic Endogenous Novel Regulators of Angiogenesis
Ribatti, D., Conconi, M. T., & Nussdorfer, G. G. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.2.3 · Cited by 178
Peng, L.-H., Wang, M.-Z., Chu, Y., Zhang, L., Niu, J., Shao, H.-T., Yuan, T.-J., Jiang, Z.-H., Gao, J.-Q., & Ning, X.-H. (2020) · Science Advances · doi:10.1126/sciadv.aba2735 · Cited by 177
“Furthermore, v3 integrin can only be expressed on blood vessels in wound granulation, newborn vessels, and tumor endothelial cells but not in normal skins, organ systems, or resting endothelial cells (36).”
Lundin, L., Larsson, H., Kreuger, J., Kanda, S., Lindahl, U., Salmivirta, M., & Claesson-Welsh, L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908930199 · Cited by 177
Inhibition of Angiogenesis in Vivo by Plasminogen Activator Inhibitor-1
Stefansson, S., Petitclerc, E., Wong, M. K., McMahon, G. A., Brooks, P. C., & Lawrence, D. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007609200 · Cited by 177
Self-citationThe pathophysiology of vascular obstruction in the sickle syndromes
Kaul, D. K., Fabry, M. E., & Nagel, R. L. (1996) · Blood Reviews · doi:10.1016/s0268-960x(96)90018-1 · Cited by 176
Erb, L., Liu, J., Ockerhausen, J., Kong, Q., Garrad, R. C., Griffin, K. D., Neal, C., Krugh, B. W., Santiago‐Pérez, L. I., González, F. A., et al. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.3.491 · Cited by 176
RGD-Tachyplesin inhibits tumor growth.
Chen, Y., Xu, X., Hong, S., Chen, J., Liu, N., Underhill, C. B., Creswell, K. M., & Zhang, L. (2001) · PubMed · Cited by 176
Multimodality Cardiovascular Molecular Imaging, Part I
Sinusas, A. J., Bengel, F., Nahrendorf, M., Epstein, F. H., Wu, J. C., Villanueva, F. S., Fayad, Z. A., & Gropler, R. J. (2008) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.108.824359 · Cited by 175
Anginex, a designed peptide that inhibits angiogenesis
Griffioen, A. W., van der Schaft, D. W. J., Barendsz-Janson, A. F., Andrew, C. O. X., Struijker-Boudier, H. A. J., Hillen, H. F. P., & Mayo, K. H. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3540233 · Cited by 175
Cell adhesion and angiogenesis
Strömblad, S., & Cheresh, D. A. (1996) · Trends in Cell Biology · doi:10.1016/0962-8924(96)84942-7 · Cited by 175
Self-citationThe role of blood platelets in tumor angiogenesis
Sabrkhany, S., Griffioen, A. W., & oude Egbrink, M. G. A. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.12.001 · Cited by 175
VEGF-Activated Angiogenesis During Bone Regeneration
Kleinheinz, J., Stratmann, U., Joos, U., & Wiesmann, H. (2005) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2005.05.303 · Cited by 175
Max, R., Gerritsen, R. R. C. M., Nooijen, P. T. G. A., Goodman, S. L., Sutter, A., Keilholz, U., Ruiter, D. J., & De Waal, R. M. W. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970502)71:3<320::aid-ijc2>3.0.co;2-# · Cited by 175
Dijkgraaf, I., Rijnders, A. Y., Soede, A., Dechesne, A. C., van Esse, G. W., Brouwer, A. J., Corstens, F. H. M., Boerman, O. C., Rijkers, D. T. S., & Liskamp, R. M. J. (2007) · Organic & Biomolecular Chemistry · doi:10.1039/b615940k · Cited by 174
Xu, Q., Liu, Y., Su, S., Li, W., Chen, C., & Wu, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.012 · Cited by 174
Beer, A. J., Niemeyer, M., Carlsen, J., Sarbia, M., Nährig, J., Watzlowik, P., Wester, H.-J., Harbeck, N., & Schwaiger, M. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045526 · Cited by 174
Comparison of a Monomeric and Dimeric Radiolabeled RGD-Peptide for Tumor Targeting
Janssen, M., Oyen, W. J. G., Massuger, L. F. A. G., Frielink, C., Dijkgraaf, I., Edwards, D. S., Radjopadhye, M., Corstens, F. H. M., & Boerman, O. C. (2002) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497802320970244 · Cited by 174
Senger, D. R. (1996) · Europe PMC (PubMed Central) · Cited by 174
Angiogenesis: New insights and therapeutic potential
Tomanek, R. J., & Schatteman, G. C. (2000) · The Anatomical Record · doi:10.1002/1097-0185(20000615)261:3<126::aid-ar7>3.0.co;2-4 · Cited by 174
Angiongenesis: a new theory for endometriosis
Healy, D. (1998) · Human Reproduction Update · doi:10.1093/humupd/4.5.736 · Cited by 173
Metadata
- Authors
- Brooks, P. C., Clark, R. A. F., & Cheresh, D. A.
- Affiliations
- Scripps Research Institute (US)
- Stony Brook University (US)
- Venue
- Science
- Published
- 1994-04-22
- Volume
- 264
- Issue
- 5158
- Pages
- 569-571
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2029773366
- Cited by
- 3,020
- References
- 22
- Citations by year
- 2026: 22 · 2025: 30 · 2024: 50 · 2023: 36 · 2022: 57 · 2021: 60 · 2020: 54 · 2019: 60 · 2018: 69 · 2017: 62 · 2016: 91 · 2015: 74 · 2014: 102 · 2013: 124 · 2012: 104
- FWCI
- 31.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-50286, CA-45726, R01CA045726)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- integrin αvβ3, angiogenesis, chorioallantoic membrane, basic fibroblast growth factor, TNF-α, melanoma, monoclonal antibodies, neovascularization, therapeutic target
- MeSH terms
- Animals, Antibodies, Monoclonal, Blood Vessels, Chick Embryo, Granulation Tissue, Humans, Laminin, Melanoma, Neovascularization, Pathologic, Skin, Tumor Necrosis Factor-alpha, von Willebrand Factor, Integrins, Receptors, Cytoadhesin, Fibroblast Growth Factor 2, Receptors, Vitronectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.